Production (Stage)
Inhibikase Therapeutics, Inc.
IKT
$1.95
-$0.01-0.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 855.75% | 636.06% | -80.73% | -62.07% | -62.09% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.79% | 8.43% | -26.15% | -36.11% | -7.99% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -66.65% | -51.64% | 85.32% | -26.41% | -75.49% |
| Total Current Assets | 771.27% | 592.78% | -76.13% | -60.87% | -60.88% |
|
|
|||||
| Total Current Assets | 771.27% | 592.78% | -76.13% | -60.87% | -60.88% |
| Net Property, Plant & Equipment | -55.21% | -49.76% | -43.39% | -38.39% | -51.33% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 751.83% | 579.69% | -75.52% | -60.50% | -60.70% |
|
|
|||||
| Total Accounts Payable | 30.79% | 45.79% | 244.30% | 77.76% | 34.90% |
| Total Accrued Expenses | 40.10% | 18.58% | 16.32% | 11.12% | 60.93% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -50.53% | -26.38% | -2.55% | 2.84% | 2.93% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 102.00% | 8.58% | 78.99% | 35.55% | 58.89% |
|
|
|||||
| Total Current Liabilities | 102.00% | 8.58% | 78.99% | 35.55% | 58.89% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -82.93% | -67.27% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 99.25% | 5.81% | 71.42% | 29.38% | 50.98% |
|
|
|||||
| Common Stock & APIC | 147.46% | 143.10% | 5.16% | 5.17% | 1.06% |
| Retained Earnings | -51.08% | -41.14% | -31.19% | -31.62% | -36.68% |
| Treasury Stock & Other | 44.44% | -4,233.33% | 1,900.00% | 41.18% | -101.09% |
| Total Common Equity | 1,165.08% | 764.16% | -103.53% | -73.82% | -73.24% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1,165.08% | 764.16% | -103.53% | -73.82% | -73.24% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1,165.08% | 764.16% | -103.53% | -73.82% | -73.24% |
|
|
|||||